Ralph William Charlton III - Dec 14, 2023 Form 4 Insider Report for SPRUCE BIOSCIENCES, INC. (SPRB)

Role
Chief Medical Officer
Signature
/s/ Samir M. Gharib, Attorney-in-Fact
Stock symbol
SPRB
Transactions as of
Dec 14, 2023
Transactions value $
-$18,227
Form type
4
Date filed
12/18/2023, 08:17 PM
Previous filing
Jul 5, 2023
Next filing
Jan 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPRB Common Stock Options Exercise $0 +31.8K +125.78% $0.00 57K Dec 15, 2023 Direct F1, F2
transaction SPRB Common Stock Tax liability -$18.2K -11K -19.27% $1.66 46K Dec 15, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SPRB Restricted Stock Units Award $0 +213K $0.00 213K Dec 14, 2023 Common Stock 213K $0.00 Direct F2, F3, F4
transaction SPRB Restricted Stock Units Options Exercise $0 -31.8K -25% $0.00 95.3K Dec 15, 2023 Common Stock 31.8K $0.00 Direct F1, F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 5, 2022, the Reporting Person was granted 127,000 time-based restricted stock units ("RSUs"), subject to a 4-year vesting schedule, with 25% of the total number of RSUs to vest on December 15, 2023 (the "Annual Vesting Date") and 25% of the total number of RSUs to vest in annual installments on each anniversary of the Annual Vesting Date thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2023, 31,750 RSUs vested, with 10,980 shares being withheld for taxes, resulting in a net issuance of 20,770 shares.
F2 Each RSU represents a contingent right to receive one share of SPRB common stock.
F3 106,400 of the RSUs shall vest as to 25% on December 15, 2024, and in equal annual installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan).
F4 106,400 of the RSUs shall vest upon the achievement of specified performance goals, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan).
F5 Represents the aggregate balance of 95,250 time-based RSUs.